Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany mydrg.de

library_books

Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany

• B.S.
• Freitag, 13.03.2009

Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany (Springerlink).

Antibiotika - Arzneimittel-Resistenz - Kosten-Nutzen - Kostenvergleich - MRSA - Nosokomiale Infektionen - Outcome - Pneumonie - URL

« Die Ev. Diakonissenanstalt Karlsruhe-Rüppurr sucht zum nächstmöglichen Zeitpunkt eine Leitung der Abteilung Patientenmanagement (m / w) | Cost-Effectiveness of Linezolid vs Vancomycin in Suspected Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia in Germany | Big Pharma am Küchentisch »